NO20013946L - Fenylalaninol-derivater - Google Patents
Fenylalaninol-derivaterInfo
- Publication number
- NO20013946L NO20013946L NO20013946A NO20013946A NO20013946L NO 20013946 L NO20013946 L NO 20013946L NO 20013946 A NO20013946 A NO 20013946A NO 20013946 A NO20013946 A NO 20013946A NO 20013946 L NO20013946 L NO 20013946L
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- lower alkyl
- alkanoyl
- aryl
- halo
- Prior art date
Links
- STVVMTBJNDTZBF-VIFPVBQESA-N L-phenylalaninol Chemical class OC[C@@H](N)CC1=CC=CC=C1 STVVMTBJNDTZBF-VIFPVBQESA-N 0.000 title abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 17
- 125000001589 carboacyl group Chemical group 0.000 abstract 7
- 125000003118 aryl group Chemical group 0.000 abstract 5
- 125000001475 halogen functional group Chemical group 0.000 abstract 5
- 125000003545 alkoxy group Chemical group 0.000 abstract 4
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 4
- 125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 4
- 125000004414 alkyl thio group Chemical group 0.000 abstract 4
- 125000003435 aroyl group Chemical group 0.000 abstract 4
- 125000004644 alkyl sulfinyl group Chemical group 0.000 abstract 3
- 125000001072 heteroaryl group Chemical group 0.000 abstract 3
- 125000005010 perfluoroalkyl group Chemical group 0.000 abstract 3
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 abstract 2
- 108010000134 Vascular Cell Adhesion Molecule-1 Proteins 0.000 abstract 2
- 102100023543 Vascular cell adhesion protein 1 Human genes 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- -1 perfluoro Chemical group 0.000 abstract 2
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical group NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 abstract 1
- 102000016359 Fibronectins Human genes 0.000 abstract 1
- 108010067306 Fibronectins Proteins 0.000 abstract 1
- 108010008212 Integrin alpha4beta1 Proteins 0.000 abstract 1
- 125000005236 alkanoylamino group Chemical group 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 abstract 1
- 125000004471 alkyl aminosulfonyl group Chemical group 0.000 abstract 1
- 230000002456 anti-arthritic effect Effects 0.000 abstract 1
- 230000001088 anti-asthma Effects 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 230000003356 anti-rheumatic effect Effects 0.000 abstract 1
- 239000000924 antiasthmatic agent Substances 0.000 abstract 1
- 239000003435 antirheumatic agent Substances 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000005100 aryl amino carbonyl group Chemical group 0.000 abstract 1
- 125000004104 aryloxy group Chemical group 0.000 abstract 1
- 210000003651 basophil Anatomy 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 210000003979 eosinophil Anatomy 0.000 abstract 1
- 125000004475 heteroaralkyl group Chemical group 0.000 abstract 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract 1
- 210000004698 lymphocyte Anatomy 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 210000001616 monocyte Anatomy 0.000 abstract 1
- 230000000324 neuroprotective effect Effects 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/77—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
- C07C233/80—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12049899P | 1999-02-18 | 1999-02-18 | |
| PCT/EP2000/001168 WO2000048988A1 (fr) | 1999-02-18 | 2000-02-12 | Dérivés de phénylalaninol |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20013946D0 NO20013946D0 (no) | 2001-08-14 |
| NO20013946L true NO20013946L (no) | 2001-08-14 |
Family
ID=22390691
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20013946A NO20013946L (no) | 1999-02-18 | 2001-08-14 | Fenylalaninol-derivater |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US6420600B1 (fr) |
| EP (1) | EP1154987B1 (fr) |
| JP (1) | JP2002537283A (fr) |
| KR (1) | KR100636458B1 (fr) |
| CN (1) | CN1213020C (fr) |
| AT (1) | ATE264835T1 (fr) |
| AU (1) | AU771938B2 (fr) |
| BR (1) | BR0008368A (fr) |
| CA (1) | CA2362833C (fr) |
| CZ (1) | CZ20012984A3 (fr) |
| DE (1) | DE60010049T2 (fr) |
| DK (1) | DK1154987T3 (fr) |
| ES (1) | ES2218116T3 (fr) |
| HR (1) | HRP20010594B1 (fr) |
| HU (1) | HUP0200343A3 (fr) |
| ID (1) | ID30057A (fr) |
| IL (2) | IL144641A0 (fr) |
| MA (1) | MA26772A1 (fr) |
| MX (1) | MXPA01008178A (fr) |
| NO (1) | NO20013946L (fr) |
| PL (1) | PL349463A1 (fr) |
| PT (1) | PT1154987E (fr) |
| RU (1) | RU2238265C2 (fr) |
| SI (1) | SI1154987T1 (fr) |
| TR (1) | TR200102395T2 (fr) |
| WO (1) | WO2000048988A1 (fr) |
| YU (1) | YU58601A (fr) |
| ZA (1) | ZA200106075B (fr) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6939855B2 (en) | 1997-07-31 | 2005-09-06 | Elan Pharmaceuticals, Inc. | Anti-inflammatory compositions and method |
| MXPA02001449A (es) * | 1999-08-13 | 2002-07-02 | Biogen Inc | Inhibidores de adhesion de celdas. |
| US6380387B1 (en) | 1999-12-06 | 2002-04-30 | Hoffmann-La Roche Inc. | 4-Pyrimidinyl-n-acyl-l phenylalanines |
| US6388084B1 (en) | 1999-12-06 | 2002-05-14 | Hoffmann-La Roche Inc. | 4-pyridinyl-n-acyl-l-phenylalanines |
| WO2004103967A2 (fr) | 2003-05-20 | 2004-12-02 | Genentech, Inc. | Inhibiteurs de type thiocarbamates d'integrines alpha-4 |
| WO2006081986A1 (fr) * | 2005-02-07 | 2006-08-10 | F.Hoffmann-La Roche Ag | Combinaison de bambuterol et d'inhibiteur d'integrine |
| WO2006094640A2 (fr) * | 2005-03-04 | 2006-09-14 | F.Hoffmann-La Roche Ag | Association de roflumilast et d'un inhibiteur de l'integrine, et procede de traitement |
| US8344029B2 (en) * | 2005-07-19 | 2013-01-01 | Daiichi Sankyo Company, Limited | Substituted propanamide derivative and pharmaceutical composition containing the same |
| IL172896A0 (en) * | 2005-12-29 | 2006-06-11 | Yeda Res & Dev | Cxcr4 inhibition |
| US8877815B2 (en) | 2010-11-16 | 2014-11-04 | Novartis Ag | Substituted carbamoylcycloalkyl acetic acid derivatives as NEP |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE584914A (fr) | 1958-11-24 | |||
| US3527793A (en) | 1967-08-18 | 1970-09-08 | Bristol Myers Co | Phenylglycine derivatives |
| SU961297A1 (ru) * | 1981-02-16 | 1990-12-07 | Институт биохимии АН ЛитССР | Этиловый эфир N @ ,О-дифенилацетил-трео-DL-фенилсерина, про вл ющий противовоспалительное действие |
| IT1190378B (it) | 1985-06-21 | 1988-02-16 | Isf Spa | Derivati pirrolidonici |
| US5039805A (en) | 1988-12-08 | 1991-08-13 | Hoffmann-La Roche Inc. | Novel benzoic and phenylacetic acid derivatives |
| US5463116A (en) | 1991-07-30 | 1995-10-31 | Ajinomoto Co., Inc. | Crystals of N- (trans-4-isopropylcyclohexlycarbonyl)-D-phenylalanine and methods for preparing them |
| CN1046725C (zh) | 1994-06-20 | 1999-11-24 | 武田药品工业株式会社 | 稠合的咪唑化合物,它们的制备和应用 |
| US6306840B1 (en) | 1995-01-23 | 2001-10-23 | Biogen, Inc. | Cell adhesion inhibitors |
| US5804595A (en) | 1995-12-05 | 1998-09-08 | Regents Of The University Of Minnesota | Kappa opioid receptor agonists |
| EP0889877B1 (fr) | 1996-03-29 | 2001-08-29 | G.D. Searle & Co. | DERIVES DE PHENYLENE META-SUBSTITUES, UTILISES COMME ANTAGONISTES OU INHIBITEURS DE L'INTEGRINE ALPHAvBETA3 |
| CA2250698A1 (fr) * | 1996-03-29 | 1997-10-09 | G.D. Searle & Co. | Derives d'acide phenylpropanoique para-substitues, utilises comme antagonistes de l'integrine |
| ID19155A (id) * | 1996-12-13 | 1998-06-18 | Tanabe Seiyaku Co | Turunan-turunan piridin, pembuatannya dan intermediet untuk pembuatannya |
| EP1001764A4 (fr) * | 1997-05-29 | 2005-08-24 | Merck & Co Inc | Composes d'amide heterocycliques utilises en tant qu'inhibiteurs de l'adhesion cellulaire |
| JP3555876B2 (ja) * | 1997-08-22 | 2004-08-18 | エフ.ホフマン−ラ ロシュ アーゲー | N−アロイルフェニルアラニン誘導体 |
| EP1005446B1 (fr) * | 1997-08-22 | 2004-02-25 | F. Hoffmann-La Roche Ag | Derives de la n-aroylphenylananine |
| JP2002504534A (ja) | 1998-02-26 | 2002-02-12 | セルテック・セラピューティクス・リミテッド | α4インテグリンの阻害剤としてのフェニルアラニン誘導体 |
| US6521626B1 (en) | 1998-03-24 | 2003-02-18 | Celltech R&D Limited | Thiocarboxamide derivatives |
| GB9811159D0 (en) | 1998-05-22 | 1998-07-22 | Celltech Therapeutics Ltd | Chemical compounds |
-
2000
- 2000-02-12 HR HR20010594A patent/HRP20010594B1/xx not_active IP Right Cessation
- 2000-02-12 ID IDW00200101769A patent/ID30057A/id unknown
- 2000-02-12 TR TR2001/02395T patent/TR200102395T2/xx unknown
- 2000-02-12 JP JP2000599729A patent/JP2002537283A/ja active Pending
- 2000-02-12 EP EP00903692A patent/EP1154987B1/fr not_active Expired - Lifetime
- 2000-02-12 PL PL00349463A patent/PL349463A1/xx not_active Application Discontinuation
- 2000-02-12 MX MXPA01008178A patent/MXPA01008178A/es active IP Right Grant
- 2000-02-12 ES ES00903692T patent/ES2218116T3/es not_active Expired - Lifetime
- 2000-02-12 HU HU0200343A patent/HUP0200343A3/hu unknown
- 2000-02-12 RU RU2001124601A patent/RU2238265C2/ru not_active IP Right Cessation
- 2000-02-12 DE DE60010049T patent/DE60010049T2/de not_active Expired - Lifetime
- 2000-02-12 CZ CZ20012984A patent/CZ20012984A3/cs unknown
- 2000-02-12 AT AT00903692T patent/ATE264835T1/de not_active IP Right Cessation
- 2000-02-12 IL IL14464100A patent/IL144641A0/xx active IP Right Grant
- 2000-02-12 CN CNB008038694A patent/CN1213020C/zh not_active Expired - Fee Related
- 2000-02-12 PT PT00903692T patent/PT1154987E/pt unknown
- 2000-02-12 AU AU25486/00A patent/AU771938B2/en not_active Ceased
- 2000-02-12 BR BR0008368-2A patent/BR0008368A/pt not_active Application Discontinuation
- 2000-02-12 CA CA002362833A patent/CA2362833C/fr not_active Expired - Fee Related
- 2000-02-12 YU YU58601A patent/YU58601A/sh unknown
- 2000-02-12 DK DK00903692T patent/DK1154987T3/da active
- 2000-02-12 KR KR1020017010537A patent/KR100636458B1/ko not_active Expired - Fee Related
- 2000-02-12 SI SI200030405T patent/SI1154987T1/xx unknown
- 2000-02-12 WO PCT/EP2000/001168 patent/WO2000048988A1/fr not_active Ceased
- 2000-02-17 US US09/506,062 patent/US6420600B1/en not_active Expired - Fee Related
-
2001
- 2001-07-24 ZA ZA200106075A patent/ZA200106075B/en unknown
- 2001-07-30 IL IL144641A patent/IL144641A/en not_active IP Right Cessation
- 2001-08-14 NO NO20013946A patent/NO20013946L/no not_active Application Discontinuation
- 2001-08-17 MA MA26298A patent/MA26772A1/fr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1154987T3 (da) | Phenylalaninolderivater | |
| US6423728B1 (en) | Heterocyclic thioamide derivatives | |
| EP1415986A4 (fr) | Composes spiro | |
| NZ505089A (en) | PPAR-gamma receptor activators, useful for the treatment of skin disorders | |
| NO943625D0 (no) | Monoklonale antistoffer mot interferonreseptoren med nöytraliserende aktivitet mot type-I-interferon | |
| ID24219A (id) | Turunan dibenzotiazotiazepina kristalin dan penggunaannya sebagai zat antipsikotik | |
| ATE204471T1 (de) | Pyrimidin- oder triazincarbonsäurederivate zur verwendung als arzneimittel | |
| BR9609092A (pt) | Prendedores de aba de fita para artigos absorventes descartáveis | |
| PL321593A1 (en) | Method of actiwating biological tissue gluing adhesives, bonding agents and haemorrhage arresting agents by use colour-changing chromophores | |
| HU9303009D0 (en) | New 2-saccharinyl-methyl-aryl-carboxylat derivatives and pharmaceutical preparations containing said compounds | |
| ATE386035T1 (de) | Medizinische verwendung von zwitterion- verbindungen als modulatoren des cftr -kanals | |
| ATE99531T1 (de) | Windel mit dichtungsklappen. | |
| FR2767526B1 (fr) | Composes bi-aromatiques relies par un radical heteroethynylene et compositions pharmaceutiques et cosmetiques les contenant | |
| DE3880499D1 (de) | Cyanhydrinderivate und deren verwendung in fluessigkristallmaterialien und vorrichtungen. | |
| NZ335318A (en) | (o-acyl-p-N-acylamino-phenyl)-O-phosphoethanolamines with anti-inflammatory activity | |
| TR200301890T2 (tr) | HIV-İnhibe edici N-Aminoimidazol türevleri. | |
| IT1270995B (it) | Derivati dell'acido 2-(2-azetidinon-n-il)-3-butenoico e loro uso nella sintesi di cefalosporine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |